Skip to main content
search
Highlights
    Home  // . //  Oliver Wyman Health //  When Healthcare’s Past and Future Collide

    When Healthcare’s Past and Future Collide

    Table of Contents

      Banging Down The New Front Door

      [insert summary]

      [add "Read Entire Article" button to https://health.oliverwyman.com/2018/11/banging-down-the-new-front-door.html]

       

      Pharma’s patent cliff exposes a deeper strategy problem

      Pharmaceutical companies must rethink portfolio strategy to close a widening growth gap. Building a resilient portfolio strategy is not a one-time redesign.

      What PBM reforms mean for drug manufacturers today

      PBM reform is shifting market access from rebate-driven contracting to value-based competition. Learn what pharmaceutical manufacturers should do now.

      How speed and scale can drive innovation in cancer care

      Edward Kim explains how City of Hope is accelerating clinical trials and expanding access to next-generation cancer care.

      Why China is becoming the top biopharma innovation hotspot

      Pharma companies face a historic patent cliff. China’s emerging market for drug discovery, clinical trials, and licensing deals can strengthen pipelines.